OncoSec

YTD

ALL

Why Robinhood?

You can watch OncoSec and buy or sell other stocks, options, and ETFs commission-free!

About ONCS

OncoSec Medical, Inc. is a biotechnology company focused on designing, developing and commercializing therapies and proprietary medical approaches to stimulate and to guide an anti-tumor immune response for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor.

CEO

Robert H. Arch, PhD

CEORobert H. Arch, PhD

Employees

—

Employees—

Headquarters

Ewing, New Jersey

HeadquartersEwing, New Jersey

Founded

2008

Founded2008

Employees

—

Employees—

ONCS Key Statistics

Market cap

823.62K

Market cap823.62K

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

812.70

Average volume812.70

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$1.31

52 Week high$1.31

52 Week low

—

52 Week low—